Nuclear Medicine: Page 351

IBA inks SAIC-Frederick deal, debuts new radionuclides

By AuntMinnie.com staff writers

Belgian nuclear medicine products firm Ion Beam Applications (IBA) has signed a contract manufacturing and distribution agreement with SAIC-Frederick.

October 1, 2006

MDS Nordion gets FDA OK for TheraSphere clinical trials

By AuntMinnie.com staff writers

Canadian radioisotope developer MDS Nordion reported that it has received U.S. Food and Drug Administration (FDA) approval to begin clinical trials of its TheraSphere treatment for liver cancer.

September 25, 2006

Advanced Medical Isotope buys Neu-Hope

By AuntMinnie.com staff writers

Medical isotope developer Advanced Medical Isotope of Kennewick, WA, has acquired UTEK subsidiary Neu-Hope Technologies (NHT) in a stock transaction.

September 24, 2006

Segami, Mid-Atlantic Imaging debut cardiac gamma camera

By AuntMinnie.com staff writers

Nuclear medicine software developer Segami and gamma camera developer Mid-Atlantic Imaging have released the maiCAM180, a portable, dual-detector gamma camera optimized for cardiac SPECT imaging in small office rooms and portable or mobile operations.

September 20, 2006

Cambridge Isotope acquires ABX

By AuntMinnie.com staff writers

Cambridge Isotope Laboratories (CIL) of Boston has acquired 100% of the stock of ABX Advanced Biochemical Compounds of Radeberg, Germany.

September 19, 2006

Dual-time-point PET spots local, distant breast metastases

By Jonathan S. Batchelor

Dual-time-point FDG-PET can aid in the differentiation of malignant from normal tissue in the breast, as well as in the detection of locoregional and distant metastasis from primary breast cancer, according to scientists from the Hospital of the University of Pennsylvania in Philadelphia. The technique involves scanning a patient at two distinct time intervals in order to quantify radiotracer uptake.

September 13, 2006

Two studies define role of molecular imaging, therapy in endocrine carcinoma

By Shalmali Pal

Digestive endocrine tumors would seem to be as intricate as the digestive system itself, so it's no wonder that clinicians are searching for the best imaging modality to diagnose, differentiate, and treat endocrine tumors. Two recent studies looked at how molecular imaging and therapy fared in this disease. A group from Poland evaluated endocrine cancer response to treatment with a radiolabeled somatostatin analogue, while researchers in France tested two molecular imaging techniques in endocrine cancers as a tool for diagnosis and staging.

September 13, 2006

Cell>Point names Rollo as president

By AuntMinnie.com staff writers

Radiopharmaceutical developer Cell>Point of Englewood, CO, has named former Philips Medical Systems chief medical officer Dr. David Rollo as its president.

September 12, 2006

Neoprobe, Estech expand distribution deal

By AuntMinnie.com staff writers

Gamma camera probe developer Neoprobe has expanded its distribution agreement with Estech of San Ramon, CA.

September 10, 2006

MDS Nordion Q3 posts flat revenues

By AuntMinnie.com staff writers

Canadian radioisotope developer MDS Nordion reported no increase in revenues for its fiscal 2006 third quarter (end-July 31).

September 6, 2006

Philips notches 1,000th CardioMD install, debuts Xcelera 2.1

By AuntMinnie.com staff writers

Philips Medical Systems is displaying the latest iteration of its integrated cardiovascular information application, Xcelera 2.1, at the American Society of Nuclear Cardiology meeting in Montreal this week.

September 6, 2006

Positron partners with MIMvista

By AuntMinnie.com staff writers

PET developer Positron of Houston has entered into a partnership with MIMvista, a Cleveland-based developer of advanced visualization software for nuclear medicine.

September 6, 2006

Previous Page

Page 351 of 440

Next Page